Carvedilol for portal hypertension in patients with cirrhosis
- 26 March 2010
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 51 (6), 2214-2218
- https://doi.org/10.1002/hep.23689
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertensionJournal of Hepatology, 2009
- Acute Hemodynamic Response to β-Blockers and Prediction of Long-term Outcome in Primary Prophylaxis of Variceal BleedingGastroenterology, 2009
- Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosisJournal of Hepatology, 2009
- The management of portal hypertension: Rational basis, available treatments and future optionsJournal of Hepatology, 2008
- Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated CirrhosisGastroenterology, 2007
- Hepatic Vein Pressure Gradient Reduction and Prevention of Variceal Bleeding in Cirrhosis: A Systematic ReviewGastroenterology, 2006
- Beta-Blockers to Prevent Gastroesophageal Varices in Patients with CirrhosisThe New England Journal of Medicine, 2005
- Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosisThe Lancet, 1995
- Endoscopic Measurement of Variceal Pressure in Cirrhosis: Correlation With Portal Pressure and Variceal HemorrhageGastroenterology, 1989
- Prediction of the First Variceal Hemorrhage in Patients with Cirrhosis of the Liver and Esophageal VaricesThe New England Journal of Medicine, 1988